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ABSTRACT 
 
Across tropical Africa, febrile children are treated for malaria either with or without 
confirmation thus resulting in failure to diagnose and treat other co-morbidities like 
urinary tract infections (UTI) and upper respiratory tract infection (URTI) that may 
coexist with malaria. This cross-sectional study examined coexisting malaria with 
UTI and further assessed the antimicrobial susceptibility pattern of the isolated 
organisms among children aged less than 5 years presenting with fever and malaria. 
Thick and thin blood films were used for the diagnosis of malaria and urine samples 
were collected in sterile, widescrewed-mouth, leak proof containers for culture and 
sensitivity. Organisms isolated were identified and tested for their antimicrobial 
sensitivity patterns using the Kirby-Bauer disc diffusion method. Prevalence of 
malaria with coexisting UTI was 3.3% with majority (58.0%) of the participants 
being female. Age was associated with malaria and UTI co infection prevalence of 
co-infection being 24-36 age group. Escherichia coli (50%) Staphylococcus aureus 
(25%),Klebsiella species(16.70%)  and Proteus species (8.3%) were isolated.Co-
infection of malaria and UTI was present in febrile children under five years in 
Muhimbili National Hospital. Non detection implies that such hidden morbidity 
would be untreated. Health care personnel should rule out UTI when managing 
febrile children less than five  years with malaria. 
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    CHAPTER ONE 
 1.0 NTRODUCTION 
 
 1.1 General Introduction 
For decades, majority of African children under the age of five years have been 
presumptively treated for malaria once they present with fever (Rougemont et al., 
1991; Kallander et al., 2004; English et al., 2009). This might be due to the fact that 
malaria has been a global problem. 
 
Public health studies have established that more than 50% of African children who 
present with fever to healthcare centers do not have malaria infection (Gething et al., 
2010). In countries where presumptive diagnosis has become a standard practice, 
various challenges in treatment and management arise as the origin of febrile illness 
may be due to other causes such as bacterial and viral infections and not exclusively 
malaria (Kallander et al., 2004).  
 
Co-existence of urinary tract infection (UTI) with these febrile illnesses especially 
malaria has been reported by several authors across the African continent (Akpede 
and Skyes, 1992; Okwara et al., 2004; Okunola et al., 2012). In Nigeria, 9% of 
children under the age of five years had malaria coexisting with UTI (Okunola et al., 
2012). It is difficult to accurately assess the incidence of UTIs, because they are not 
reportable diseases (WHO 2000; Berg et. al. 2004). The prevalence of UTI in Africa 
and particularly in Tanzania is not well known, this is due to the non specific 
presenting symptoms (Akpede and Skyes, 1992).   
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Children with fever are a majority in the various emergency rooms all over the 
world, and especially in the tropical countries (Akpede and Skyes, 1992). Most 
children of under five years in sub-Saharan Africa will be treated for malaria, 
whether confirmed or not (Akpede and Skyes, 1992). It therefore follows that some 
of the morbidities other than malaria may go unnoticed. The co-morbidities with 
malaria that may have similar presentation among under-fives therefore are difficult 
to detect, and diseases like respiratory tract infections (RTI) and urinary tract 
infections (UTI) are left to debilitate affected children (Carroll, et al., 1994). The 
exact burden of UTI co-existing with malaria in Tanzania remains ill defined. This 
study looked at the co-existence of UTI in under- fives year with a primary diagnosis 
of malaria from MNH.  
 
The study indicated that UTI is a silent comorbidity in children aged less than 5 
years with malaria and there is a need to evaluate these children in order to prevent 
the longterm morbidity of chronic renal diseases such as blood pressure, renal 
scaring and renal failure (Benardo.et.al., 1997). The results of this study will be 
valuable in the management of childhood diseases and in the reduction of morbidity 
and mortality in children. 
 
1.2  Statement of the Problem 
UTI is a leading cause of morbidity in children, especially those less than five years 
old. Malaria is the leading cause of morbidity and mortality, particularly in sub-
Saharan Africa (Okwara 2004). UTI is known to co-exist with these common 
childhood diseases. Diagnosis of malaria is commonly based on clinical features only 
as most fever would almost invariably be managed for malaria without recourse to 
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identifying the underlying cause or ascertaining its coexistence with other 
morbidities, including UTI. Thus, cases of UTI and other morbidities could be 
missed. 
 
1.3 Objective of the Study 
The main objective of the study was: To determine the co-existence of urinary tract 
infection and malaria among children under five year attending at Muhimbili 
National Hospital. 
 
1.3.1 Specific Objectives 
(i) To determine the prevalence of UTI cases among under five children who are 
currently treated for malaria. 
(ii) To establish the most common pathogens of UTI among under five children. 
(iii) To assess antibiotics susceptibility test to the specific isolate pathogen  
 
1.4  Significance of the Study 
Although frequently encountered and well researched, diagnosis and management of 
UTI continue to be a controversial issue with many challenges for the clinician. 
Prevalence studies have shown that UTI may often be missed on history and physical 
examination, and the decision to screen for UTI must balance the risk for missed 
infections with the cost and inconvenience of testing. Interpretation of rapid 
diagnostic tests and culture is complicated by issues of contamination, false test 
results, and asymptomatic colonization of the urinary tract with nonpathogenic 
bacteria. The appropriate treatment of UTI has been controversial and has become 
more complex with the emergence of resistance to commonly used antibiotics. 
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This study will provide an up-to-date and some useful baseline information about 
diagnosis and management for the clinician and academicians, and identify the main 
areas of improvement in co-existence of UTI in children under five years with 
primary diagnosis of malaria and hence will give the proper treatment and 
management.  
  
1.5 Hypotheses 
(i) The prevalence of UTI is high in under five children with malaria at MNH 
(ii) E. coli is the most common pathogen causing UTI in under five children with 
malaria at MNH 
(iii) UTI pathogens are most susceptible to the specific antibiotic tested. 
 
1.6    Ethical Consideration 
Permission to conduct this study was requested from the Executive Director (ED), 
MNH, using a letter of introduction from the Open University of Tanzania. Also 
explanation concerning the purpose of this study was given to the ED and other in 
charges of the respective units. All information obtained in this study will remain 
confidential. 
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    CHAPTER TWO 
                    2.0 LITERATURE REVIE 
 
2.1 Historical background of UTI, Malaria and UTI and Malaria co 
Existence and Misdiagnosis 
 Urinary tract infection (UTI) is one of the most common diseases, occurring from 
the neonate up to elderly age group (Forbes 2002). It is a bacterial disease that infect 
the urinary system, that is kidneys, ureters the bladder and the urethra Women tend 
to get more bladder infections than men, this is probably because women have 
shorter urethras, so it is easier for the germs to move up to their bladders (Eugene, 
2004). Having sex can make it easier for germs to get into the urethra also the use of 
contraception (Nester.et al 2004). Urinary tract infections (UTI) in young children 
have been associated with serious long-term complications such as renal scarring, 
hypertension and renal failure (Stamm and Hooton, 2002). The presenting symptoms 
of UTI in children are non-specific. If UTI is not suspected, a urine sample is not 
obtained, UTI cannot be diagnosed. There is evidence that the diagnosis is often 
missed (Habte et al, 2009).    
 
Urinary tract infection (UTI) is a problem that is frequently encountered by pediatric 
healthcare providers (Anoukoum et al., 2002) Over recent decades, the importance of 
UTI has been increasingly recognized, in particular the role of UTI as an occult 
cause of febrile illness in young children (Freedman, 2007). The evolving state of 
knowledge about pediatric UTI leaves many questions and controversies. The 
epidemiology of UTI during childhood varies by age and gender (Shaw et al, 1998). 
Screening studies in emergency departments suggest that up to 5% of children under 
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the age of 5 presenting with fever have UTI, and over half of these would have been 
given alternative diagnoses such as otitis media, upper respiratory tract infection and 
pneumonia had the urine not been screened as part of the study (Larcombe, 1999). 
 
Malaria is a vector borne disease both in terms of geographical distribution, 
incidence morbidity and mortality it causes (NMC, 2008).Its estimated that about 
90% of the 300 to 500 million clinical cases each year which result into1.5 to 2.7 
million deaths occur in sub Saharan Africa(WHO, 1993). Pregnant woman and 
children under 5 years old are most at risk of severe malaria (WHO, 1993). 
 
In Africa, malaria is a big problem that affects socio-economic and political factors 
which may accompany high death rate (WHO, 1995). In southern Sahara desert, 
Malaria is responsible for about10% of hospital admission and about 30% of 
outpatient consultation, imposing direct cost on both government and patients 
(WHO, 1995). 
 
Fever presenting in children less than five years of age in malaria endemic areas will 
almost always be treated as cases of malaria (Akpde, 1992). However fever is a 
common feature to other childhood illnesses including RTI and UTI (Pappas, 1991). 
Malaria is known to co-exist with these other morbidities including UTI (Okwara et 
al, 2004). Undiagnosed and poorly treated UTI can lead to immediate and long term 
sequelae. Reliance on clinical features for the identification of presence of the co-
morbidity could be quite tasking in the absence of discriminatory features (Gordon, 
1990). Furthermore, UTI is known to co-exist with these common childhood diseases 
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such as Malaria, Respiratory tract infection and Pneumonia. (Bauchner et al., 1984) 
Therefore, the child presenting in such facilities with fever would almost invariably 
be managed for malaria without recourse to identifying the underlying cause or 
ascertaining its coexistence with other morbidities, including UTI (Foxman, 2002). 
Also, when malaria and UTI co-exist, the features manifested by the child would 
most likely be interpreted as malaria, and it is unlikely that the child with positive 
smear for malaria will be investigated further for UTI or other morbidities.  
 
Therefore, the prevalence of these co-morbidities would be under-estimated and 
under-reported (Berg et al., 2003). UTI has been reported in patients with malaria, 
and prevalence rates of up to 13.3% have been reported in children with malaria aged 
three months to 12 years (Okwara et al., 2004.Biyikli et al., 2004). 
 
2.2  Prevalence of UTI in Children Under Five Years 
Urinary tract infections (UTIs) are common in kids (Forbes 2002). By the time 
they're five years old, about 8% of girls and 1-2% of boys have had at least a 
symptomatic, culture-confirmed UTI. (Forbes 2002). The prevalence of UTI in 
febrile infants is greater in less than five years worldwide (Bernador et al., 1997).  
 
Urinary tract infections affect about 3% of children in the United States every year 
(Forbes 2002). UTIs account for more than one million visits to pediatricians’ offices 
every year (Forbes, 2002). The true prevalence of UTI in acutely ill children 
presenting in UK and Africa in general practice is therefore not well known (Stamm, 
2001). There is limited information on clinical epidemiology of UTI children in Dar 
es Salaam. 
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2.3  Prevalence of Malaria in Children Under Five Years 
Approximately 5% of the world’s population is infected with malaria (Akpede and 
Skyes, 1992). Malaria remains one of the major threats to under five children public 
health and economic development in Africa (WHO, 2003). It is estimated that three 
million death results from malaria throughout the world, with Africa having more 
than 90% of this burden (Breman et  al., 2004). 
 
Malaria is the major cause of outpatient and inpatient of children less than five years 
of age at health facilities in Tanzania (WHO, 2000). The high burden of malaria in 
Tanzania is due to the fact that, every year 14-18 million new malaria cases are 
reported (MOH, 2011). The annual incidence rate is 400-500/1,000 people and this 
number doubles for children less than five years of age (MOH, 2011). There are 
100,000-125,000 annual deaths due to malaria, 70,000-80,000 in under-fives (Mercia 
et al., 2004). Dar es Salaam is one of the regions with high prevalence of malaria in 
Tanzania.(NMC 2008). It’s reported that the burden of malaria and the consequence 
of the disease in the population is high with an overall prevalence of 39.2% among 
under- five children (MOH, 2011). 
 
2.4 Diagnosis of UTI  
2.4.1 Urine Collection and Laboratory Diagnosis of UTI  
A morning mid stream urine sample is preferred for UTI diagnosis in which urine is 
collected in a sterile screwed mouth container (Chessebrough, 1984). The 
examinations generally is based on microscopic examination of a wet film of 
uncentrifuged urine to determine whether the polymorphs (pus cells) are present in a 
numbers indicative of infection in the urinary tract, and the culture of urine to 
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determine whether it contains a potentially pathogenic bacterium in numbers 
sufficient to identify it as the causal infecting organism (significant bacteriuria) 
(Marray et al., 2003. Eugene et al, 2004).  
 
Some polymorphs are usually present in the urine of healthy uninfected persons and 
it is only if their number is clearly greater than the normal values that the finding of 
pus cells is indicative of urinary tract infection (Forbes, 2002). The film is observed 
with the high power field (HPF) (x40) dry objective of the microscope 
(Chessebrough, 1984). The significant bacteriuria count that is suggestive for UTI 
pathogen is leucocytes >5HPF (Chessebrough, 1984). 
 
Organisms isolated is identified and tested for their antimicrobial sensitivity patterns 
using the Kirby-Bauer disc diffusion method. The antibiotic discs to use are 
ciprofloxacin, gentamycin, nitrofuranton, ampicillin, amikacin, sulphurmethoprim, 
erythromycin, amoxicillin cloxacillin, Vancomycin, Penicillin and Impenum. The 
sensitivity of the disc is determined by measuring the zone size after overnight 
incubation aerobically at 370c (Chessebrough, 1984). 
 
2.4   UTI and Malaria Co-Existence to Under Five 
 Co-infection of malaria and UTI is not a new phe-nomenon. There is generally 
under-reporting and underestimation of these conditions in children especially as 
fever, a symptom, is common in both infections (White, 1989; Musa-Aisien et al., 
2003; Okunola et al., 2012). However, the magnitude of the problem of UTI co-
existing with malaria, particularly in malaria-endemic areas, is uncertain. The 
consequences of missed diagnosis and inadequate treatment of UTI have been 
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reported by several authors (Bauchner, 1987). The need to identify cases of UTI, 
either alone or in co-existence with other morbidities, cannot be over-emphasized. 
 
2.5  UTI Control and Treatment 
Antibiotic medicine and home care are effective in treating and controlling most of 
the urinary tract infections (UTIs) in children (Okwara et al., 2004). The main goal 
of treatment is to prevent kidney damage and its short- and long-term complications 
by eliminating the infection quickly and completely (Benardo et al., 1991). Early 
evaluation and treatment are very important. The number of days a child will need to 
take these medicines depend on the type of antibiotic (Okwara et al., 2004). Children 
present with non-specific symptoms and signs making the diagnosis of UTI in 
children challenging, furthermore obtaining urine specimen for confirming the 
diagnosis of UTI is difficult resulting in presumptive treatment of these patients 
(Shaw et al., 1998). Effective and appropriate treatment depends on clinician's high 
index of suspicion which is influenced by knowledge of the prevalent bacteriological 
uropathogens and antimicrobial susceptibility pattern in the specific area of practice 
(Musa-Aisien et al, 2003 Shaw et al., 1998). It is recommended that children 
admitted with fever should be evaluated for UTI and if urine confirmed for germs 
then sensitivity should guide the choice of antimicrobials in their treatment (Mackie 
and McCartey, 1989). 
 
2.6  Malaria Control and Treatment 
The major determinants related to malaria control include; The parasite with its many 
biological options and genetic diversity, the vector with tremendous differences in 
behaviors and transmission capacity, the human host with biological behavior, 
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political and social ramification, the environment such as altitude, temperature, 
rainfall and global warming (Bakshi et al., 2004; Fogg et al., 2004) It is also 
important to correctly identify vector species in nature and to target vector control to 
coincide with blood feeding and resting behavior of the vector species (Fogg et al., 
2004). 
 
The role of plasmodium development in the mosquito depends primarily on 
temperature, hence these relationships play a great role in parasite survival and 
parasite growth, impacting both the probability and intensity of transmission (Bakshi 
et al., 2004; Fogg et al., 2004). Also personal knowledge about environmental issues 
and the relationship between the environment and vector control are vital (NMC, 
2008). Treatment of malaria follows two strategies, clinical cure and radical cure 
(Bakshi et al., 2004; Fogg et al., 2004). A clinical cure is accomplished when 
symptoms are revealed, in case of malaria, symptoms cease because asexually 
reproducing parasites are eliminated from peripheral circulation.  
 
However this treatment does not mean that all parasites have been eradicated from 
the body. Prompt treatment is recommended for all symptoms of the disease, within 
24 hours if possible (Bakshi et al., 2004; Fogg et al., 2004). Early treatment will 
shorten the duration of malaria and prevent complications (Bakshi et al., 2004; Fogg 
et al., 2004). To avoid resistance, the best available treatment, artemisinin-based 
combination therapy (ACT) should be used (WHO, 2009). ACT is used to reduce the 
chances of P. falciparum becoming resistant to either drug (WHO, 2009). 
Appropriate drugs should be given in adequate dosage and correctly administered 
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during the period of time recommended (Van Vugt et al., 1999). Coartem has 
become the national medicine of choice to treat malaria in Tanzania, known as ALU. 
 
Radical cure is the elimination of all parasites from the body including secondary 
tissue schizonts (Bakshi et al., 2004; Fogg et al., 2004). Various strains of P. 
falciparum and P.vivax have become resistant to chloroquine. Successful treatment 
of these infections requires the use of alternative antimalarias such as combination of 
pyrimethamine and sulfadoxine (SP) or Quinine (Bakshi et al., 2004; Fogg et al., 
2004). 
 
 Children attending at MNH are referred from lower Health facilities. Febrile 
children have been investigated for malaria, and once confirmed they are treated 
according to WHO guideline. For those febrile without diagnosed malaria initially 
are treated empirically following WHO recommendations. Recommended first line 
antibiotics for the treatment of UTI include Amoxillin and Cotrimazole (WHO, 
2005).  
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CHAPTER THREE 
3.0 METHODS AND MATERIALS 
 
3.1   Methodology 
3.1.1   Study Area 
MNH was selected purposively as a study area. It’s a National referral hospital, a 
focal point of our country which is found in Dar es Salaam region, Ilala district. Dar 
es Salaam is located in the east coast of Tanzania. Is the largest city of the country 
and is the commercial city. Dar es Salaam has an area of 1393 Km2(city  profile for 
Dsm 2004), which composes three districts namely Ilala; Kinondoni and Temeke. 
The population of Dar es Salaam is about 4.4 million people, according to the 2012 
census, Dar es Salaam is the most populated city in Tanzania. The population of 
children under five years in Dar es Salaam is about 33.3% of the total population 
according to 2012 census. 
  
3.1.2  Study Design 
The study was a cross sectional, which was conducted in both inpatient and 
outpatient pediatric clinic. The study involved both quantitative and qualitative 
research design. 
 
3.1.3  Study Population 
The study population was under five year children (inpatient and outpatient) who 
were positive for malaria. The children were then examined for UTI.  Checkup was 
done at Central Pathology Laboratory at MNH. 
 14
3.1.4   Urine Collection 
Urine was collected in the screwed mouth sterile container and sent in the laboratory 
within one hour of collection for investigation, if delayed the specimens were stored 
in the refrigerator for not more than 12 hours. 
 
3.1.5   Urine Laboratory Examination 
Mid stream urine (MSU) sample was collected from patients. All urine samples were 
examined within one hour after collection. The specimen was examined 
uncentrifuged and subjected to culture in the Cystine Lactose Electrolyte Deficiency 
(CLED) and Blood Agar (BA) media, then to the Microscopy. CLED is the medium 
that favour growth of gram negative microbes such as E.coli, Klebsiella species, 
Proteus and Psedomonus species. BA favour the growth of gram positive microbes 
such as Staphylococcus species. A calibrated coiled wire loop of 1 micron were 
dipped in the urine sample and inoculated in the both media and incubated overnight.  
 
The growth of colonies was examined and counted if only was pure growth (not 
contaminated). A colony count of 105 used as a criterion for interpreting and 
reporting results as urinary tract pathogens. Other reporting was non-significant 
growth if was less than 103, or mixed growth if more than one organism grew 
(Chessebrough, 1984.Mackie and McCartey, 1989). 
 
For pure grow of 104 more identification was done by gram staining method to 
examine if its gram positive or negative, also biochemical test such as Indole, 
Oxidase, Catalase and Coagulase test were used to identify specific microbe 
responsible for causing such a particular infection. E. coli  tested  positive for indole 
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and negative for oxidase, Klebsiella tested  negative for both indole and oxidase, 
Psedomonus  tested  positive for oxidase but negative indole, whereas  Proteus  test 
negative for both indole and oxidase but had a distinctive characteristic of swamming 
on BA (Mackie and McCartey, 1989). 
 
Examination of urine microscopically was done by determining white blood cells in 
the urine. The urine was centrifuged and the deposit was examined in the microscope 
under 10 or 40 magnification, the leucocytes counted above WBC was noticeable as 
a pathogens (Chessebrough, 1984). 
 
3.1.6   Study Period 
The study carried out for four months from February to June 2014. 
 
3.1.7   Sample Size 
Children who enrolled in the study ware sampled to get the sample size of 366 
patients by purposively sampling method. The sample size was calculated using the 
formula below which mostly depended on the prevalence of malaria. 
N=z2p (100-p)/e2 
Where by: 
N=total number of participant 
Z=1.96 confidence interval 
E=marginal of error which correspond to the level of precision of results desired 
(0.05) 
P=prevalence. In this study, the estimate of prevalence of malaria in under five 
years children=39.2. 
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N=1.962x 0.392 (1-0.392)/0.052 
N=366 
 
3.1.7   Sampling Method 
It was a purposive sampling study that was carried out at the New Pediatric Complex 
ward (NPC), at MNH. Urine sample were obtained from a patient that had primarily 
diagnosed for malaria or were treated for malaria. UTI was confirmed based on the 
culture. 
 
3.1.7.1   Inclusion Criteria 
Children with age between 6-59 months were investigated, because at this age it is 
very possible to understand if the child is having any abnormality, also is easy to 
collect the urine in asceptic manner. Children presented with fever, nausea, vomiting, 
body malaise. Children presented with difficult in micturation 
 
3.1.7.2  Exclusion Criteria 
Children with the following features were excluded 
(a) Exposed to antibiotics within ten days preceding the evaluation; 
(b) History of urinary tract structural abnormalities as determined from their 
medical records or patients whose symptoms suggested abnormalities of the 
urinary tract; 
(c) Male subjected with recurrent UTI; 
(d) Urologic manipulations such as catheterization carried out within 72 h 
preceding the evaluation; 
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(e) Pre-existing conditions known to be associated with immunosuppression, 
such as protein-energy malnutrition, sickle cell anemia, malignancies, Human 
Immunodeficiency Virus infection/acquired immunodeficiency syndrome; 
and 
(f) Ultimate management for other morbidities instead of malaria and/or UTI, 
such as bronchopneumonia. 
 
For each child, a detailed history was obtained with emphasis on fever, symptoms 
referred to the urinary tract infection (i.e., dysuria, loin pain, abdominal pain,) and 
use of antibiotics and previous urologic manipulations. 
 
3.1.8   Data Analysis 
Data analysis was done using Statistical Package for Social Sciences (SPSS) 20 
version. For objective 1 and 2 cross tabulation used to find the associatin and 
correlation. For objective 3 percentage was used. Datasheet was used for data 
analysis.  Means and Standard deviations (with ranges) percentages and proportions 
were calculated. The descriptive analysis of demographic status was obtained (age 
and sex). Clinical information was degree of parasitemia and the confirmed microbe 
isolated. The prevalence of UTI in these sub-groups was compared. Degrees of 
association was assessed using the Chi squared test, and P-values less than 0.05 was 
regarded as significant. 
 
3.1.8.1 Pre-test 
Tools used for data collection was tested to ten known samples of urine from MNH 
Central Pathology Laboratory museum. These samples had similar characteristics as 
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to those targeted in the study. The aim of the pre-test was to test whether the tools 
provide the information required. 
 
3.1.9  Limitation of the Study 
The sample size was 366, however 10 of it were mixed growth of Gram Positive 
Cocci(GPC) and Gram Negative Rod(GNR), Bacillus or Coliforms contamination, 
so needed a repeat. The investigator couldn’t  manage, this because: 
(i) The selection of study unit was based on availability during the period of data 
collection, to recollect the sample the patient were already discharged so it was 
impossible. 
(ii) The collection of information mainly based on the respondent opinion on the 
subject matter, therefore there might be an error due to exaggeration of some 
information. 
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 CHAPTER FOUR 
     4.0 RESULTS 
 
4.1 Introduction 
This chapter presents the results collected in the course of this study at MNH in Dar 
es Salaam region. The study was designed to investigate the Co-existence of UTI and 
Malaria to children under five years, a hospital based descriptive- cross section study 
design, which was conducted in both inpatient and outpatient at New pediatric clinic.  
 
4.2  Prevalence of UTI Cases Among children Under Five years who were 
Treated for Malaria 
4.2.1  Prevalence of UTI According to Age 
As shown in the Table 4.1 25-36 months is the group that were more affected with 
UTI.There were 8 children (66.7%), followed by 6-24 months 3 children (25%) and 
lastly 37-59 months comprising 1 child (8.3%).  
 
Table 4.1: Prevalence of UTI According to Age 
Age (in Months) Frequency Percent 
 
6-24 3 25.0 
25-36 8 66.7 
37-59 1 8.3 
Total 12 100.0 
Source: Reseach data (Ntukula, 2014) 
 
 
The percentage of participants with no bacteriuria predominated across all the age 
groups with the most from 6-24 months 252 children (71.2%), followed by 25-36 
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months 64 children, (18.1%) and the least within the 37-59 months 38 children 
(10.7%) (Table,  4.2b). 
 
Table 4.2(a): Participant without UTI by Age 
Age (in Months) Frequency Percent 
 
6-24 252 71.2 
25-36 64 18.1 
37-59 38 10.7 
Total 354 100.0 
Source: Reseach data (Ntukula,2014) 
 
 
Table 4.2(b): No UTI to Participants that were Treated for Malaria 
Age (in Months) Frequency Percent 
 
Nbg 324 91.5 
Nsg 20 5.6 
Mg 4 1.1 
Contamination 4 1.1 
 Coliform 2 .6 
 Total 354 100.0 
Source: Reseach data (Ntukula, 2014) 
 
NB:Nbg=No bacteria growth,Nsg=No significant growth, Mg=Mixed growth. 
 21
 
Figure 4.1:  Prevalence of Bacteria According to Age 
Source: Reseach data (Ntukula, 2014) 
 
 
4.2.2  Prevalence of UTI According to Sex 
More females had UTI than males.7 females (58.3%) and 5 males (41.3%) Table 4.3. 
 
Table 4.3: Prevalence According to Sex 
Gender Frequency Percent 
 
Male 5 41.7 
Female 7 58.3 
Total 12 100.0 
Source: Reseach data (Ntukula, 2014) 
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4.3   Common UTI Pathogens Isolated 
4.3.1  Most Common Pathogens 
Escherichia coli was the predominant isolate among the study participants (Table 
4.4) with the frequency of 6(50%), followed by S.aureus 3(25%), then Klebsiella spp 
2(16.7%) and last was Proteus 1(8.3%).   
 
Table 4.4: The Common UTI Pathogens Isolated  
Pathogens Frequency Percent 
 
Escherichia coli 6 50.0 
Staphylococcus aureus 3 25.0 
Klebsiella species 2 16.7 
Proteus species. 1 8.3 
Total 12 100.0 
 Source: Reseach data (Ntukula, 2014) 
 
                                           
4.3.2  Pathogens Isolated According to Age 
E.coli also was the predominant isolate in the age cohort (Table 4.5) with the 
majority of 25-36 months having 5 isolates (83.33%), 6-24 months with 1 isolate 
(16.35%). No E.coli in 37-59 months. S.aureus had 3 isolates, 2 in the 6-24 months 
(75%) and 1(25%) in the37-59 months. Klebsiella spp had 2(100%) isolates both 
within the age group of 25-36 months. Proteus spp had 1 isolates (100%) female of 
25-36 months. 
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Table 4.5: Pathogen Isolated According to Age 
Pathogen Age (months) Frequency Total 
E.coli 
 
Total 
6-24 
25-36 
1 
5 
6 
1 
5 
6 
S.aureus 
 
Total 
6-24 
37-49 
2 
1 
3 
2 
1 
3 
Klebsiella spp 
Total 
25-36 2 
2 
2 
2 
Proteus spp 
Total 
25-36 1 
1 
1 
1 
Total                                                                  12 
Source: Reseach data (Ntukula, 2014) 
 
 
Table 4.6: Correlation of Age and Bacteria 
 Bacteria Age 
Bacteria 
Pearson Correlation 1 .102 
  .753 
N 12 12 
Age 
Pearson Correlation .102 1 
 .753  
N 12 12 
Source: Reseach data (Ntukula, 2014) 
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4.3.3  Pathogens Isolated According to Sex 
Escherichia coli was the predominant isolate among the study participants (Table 
4.7), it was more among the females 4 (66.66%) than males2 (33.33%), Males with 
more strains of Staphylococcus aureus.3 (100%) Klebsiella species and Proteus 
species were among the females only, 2(100%) and 1, (100%) respectively. 
 
Table 4.7: Pathogens Isolated According to Sex 
Pathogen Sex Total 
M F 
E.coli 2(33.33%) 4(66.66%) 6(50%) 
S.aureus 3(100%) 0(0%) 3(25%) 
Klebsiella spp 0(0%) 2(100%) 2(16.66%) 
Proteus spp 0(0%) 1(100%) 1(8.33%) 
 5(41.66%) 7(58.33%) 12(100%) 
Source: Reseach data (Ntukula,2014) 
 
Table 4.8: Correlation of Bacteria and Gender 
 Bacteria Sex 
Bacteria 
Pearson Correlation 1 .200 
  .533 
N 12 12 
Sex 
Pearson Correlation .200 1 
 .533  
N 12 12 
 
Source Reseach data (Ntukula,2014) 
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4.4  UTI co-morbidity with Malaria 
4.4.1 Co-morbidity by Age 
Table 4.9: UTI co Morbidity with Malaria by Age 
Variables Present(n=12) Absent(n=354) P.value 
Age(in months)   0.10 
6-24 3(25.0%) 252(71.18)  
25-36 8(66.66%) 64(18.20) 
37-59 1(8.33%) 38(10.73%) 
Total 12(3.28%)            354(96.72%)  
Source: Reseach data (Ntukula, 2014) 
 
 
4.3.2  Co-morbidity of UTI and Malaria by Sex 
Table 4.10 shows the co infection of malaria and UTI in which females are most 
infected. 
 
Table 4.10: UTI co Morbidity with Malaria by Sex 
Variables Present(n=12) Absent(n=354)  
Gender   P.value 
Male 5(41.33%) 160(45.20%) 0.20 
Female 7(58.66%) 194(54.80) 
Total 12(3.28%) 354(96.72%)  
Source: Reseach data (Ntukula,2014) 
 
4.5 Antibiotic Susceptibility Test 
All the isolates (E. coli, S.aureus Klebsiella spp and Proteus spp) were highly 
sensitive to Ciprofloxacin (CIP), Septrine(Sxt) and Nitrofuranton (Nit) with 
sensitivities ranging from 66.7% to 100%.Gentamicin(Ge) and Penicillin(Pe) were 
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the list sensitive to all organisms showed sensitivity ranging from 0-33.3%. NIT used 
only for GNR, while Penicillin (Pe),Vancomycin (Va) and Impenum (Imp)were used 
for GPC only. 
 
Ciprofloxacin and Septrine were sensitive to 10(83.33%) isolates.Of those ten 
isolates 4 were E.coli,3 S.aureus,2 klebsiella spp and 1 Proteus spp.Amikasin was 
sensitive to 6(85.71%) isolates of which 4 were E.coli,1 Klebsiella spp and Proteus 
spp respectively. Gentamycin was sensitive to only 2(16.77%) isolates both are 
E.coli. Nitrofuranton was sensitive to 8(88.88%) isolates, 6 were E.coli and 1 
klebsiella spp and Proteus spp respectively. Ceftriaxon(CTX) was sensitive to 
4(33.33%) isolates, 2 were E.coli and 1 S.aureus and Klebsiella spp respectively.  
 
Figure 4.2: Shows the Antibiotics Susceptibility in Percentage 
Source: Research data (Ntukula, 2014) 
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Cephalothin was sensitive to 5(41.7%) isolates of which 3 were E.coli 1 klebsiella 
spp and 1 S.aureus.Vancomycin was sensitive to 3(100%) isolates of 
S.aureus.Impenum was sensitive to 2(75%) of S.aureus.Penicillin was resistant to all 
S.aureus. 
Where:CIP=Ciprofloxacin,SXT=Septrine,AK=Amikacin,GE=Gentamycin,NIT=Nitr
ofurantoin,CTX=Ceftriaxone,CPH=Cephalothin,VANC=Vancomycin,IMP=Impenu
n and PEN=Penicillin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 28
      CHAPTER FIVE 
       5.0 DISCUSSION 
 
5.1 Introduction 
Co-infection of malaria and UTI is not a new phenomenon. There is generally under-
reporting and underestimation of these conditions in children especially as fever, a 
symptom,which is common in both infections (White, 1989; Musa-Aisien et al., 
2003; Okunola et al., 2012). This study determined the prevalence of coexisting 
malaria with UTI, identified the predominant causative agent and also assessed the 
antimicrobial susceptibility pattern of the isolated organisms among children under 5 
years with malaria in Muhimbili National Hospital. The prevalence of malaria and 
UTI co-infection in this population was 3.3% with Escherichia coli as the 
predominant isolate, also females are the majority for being co infected with malaria 
and UTI. The isolates were mostly sensitive to ciprofloxacin and nitrofurantoin and 
mostly  resistant to Penicillin and gentamicin. 
 
5.2  Prevalence of UTI by Age 
The distribution of UTI among the age cohorts is shown in Table 4.5. 3 of the 12 
children (25%) aged 6- 24 months had UTI in comparison with8 (66.66%) and 
1(8.33%) of 25-36 and 37-59 respectively.25-36 month group is predominating for 
UTI(Table5). However, between 24 months and 48 months children, due to their 
developing immune system, are exposed to all manner of infectious agents which 
makes them susceptible to common infections including UTI (Okunola et al., (2012). 
Age was not associated with bacteriuria (p=0.102), Table 6. Also, probably because 
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at that age the children are trying to depend on themselves, it is the age of toilet 
teaching, they craw, walk around and playing in different environments sometimes 
without parental care. Originally there appeared to be a difference in outcomes with 
infection occurring under the ages of 2 to 5 years based on studies which found a 
higher incidence of renal scarring in this age groups (Berg et al., Gleenson et al., 
1991).  
 
In fact some studies have shown that neonates and infants may actually have a 
decreased incidence of scarring and abnormalities compared to older children 
(Biyikli et al., 2004). In other studies show that the prevalence of UTI among 
subjects with malaria was higher in children less than 24 months old, and this 
observation is comparable to the other report. This trend may be ascribed to the fact 
that the younger child has some immuneincompetence that predisposes them to 
increased incidence of infection, including UTI (Gorelick et al., 2000). 
 
 Also from Table (2b), a total of 324(88.52%) children had malaria only and 
completely no bacteria growth 20(3.825%) patients had no significant growth of 
bacteria, that is the colon forming unit(cfu) was equal or less than 103/ml.In MSU 
this is not likely to be significant quantity of potential pathogen.A threshold of 
≥100,000 CFU per ml in a voided specimen is the standard to define a positive urine 
culture (Chessebrough, 1984).  
 
Total of 4(1.09%) patients had Mixed growth of GPC and GNR, also 2(0.54%) had 
contamination of Coliforms. Total of 4(1.09%) patients had a contamination of 
Bacillus. All these may be due to poor specimen collection by the parents or 
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guardians or by the use of contaminated containers, or even a true infection. 
Distinguishing true infection from contamination in cultures with this level of growth 
may be aided by a repeat culture if the patient has not been treated by signs of acute 
infection such as the presence of pyuria (Forbes et al., 1998 Chessebrough, 1984). 
Very unfortunately it was not possible to get a repeat fresh sample from the patients 
because they were already discharged. 
 
5.3  Prevalence of UTI by Sex 
Of the 12 patients, 7 were females (58.33%) and 5 were males (41.77%)(Table 7). 
There was no significant gender difference in the prevalence of UTI ( P = 
0.20),Table 8.The slightly difference  is probably because  women have shorter 
urethras, and  close to the anus, so it is easier for the germs to move up to their  
bladders. Also there is no correlation of sex and bacteria specificity on causing 
UTI,ie any bacteria can cause UTI in a favourable environment.(Okwara et al., 
2004). 
 
5.4 The Most Common Pathogens isolated based on participant Age 
Escherichia coli was the predominant of the isolates in the age groups (Table 4.5) 
with the majority of 25-36 months having 5 isolates(83.33%),6-24 months with 1 
isolate(16.35%).No E.coli in 37-59 months.The predominance of E.coli has been 
reported also from other studies (Forbes, 2002) though there some few studies 
indicated the predominance of Staphylococcus aureus (Osegbe et al., 1991,Biyickli 
et al 2004).The predominance of Escherichia coli  in this study could imply that 
there is a predisposition to gram-negative infections in children with malaria. 
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However, this is an area that will require further investigation.  Staphylococcus 
aureus had 3 isolates,2 in the 6-24 months(75%) and 1(25%)in the37-59 months. 
Klebsiella spp had 2(100%) isolates both within the age group of 25-36 
months.Proteus spp had 1 isolates (100%) of 25-36 months. 
 
5.5 The Most Common Pathogens Isolated Based on Participant Sex 
Escherichia coli was the predominant isolate among the study participants (Table 
4.7). It was more among the females 4(66.66%)compared to 2(33.33%) of 
men.S.aureus was the predominant isolate among the males with the incidence of 
3(100%). Klebsiella spp was 2(100%)among the females only, also Proteus spp was 
1(100%) only the female. There is no relationship of bacteria causing UTI and 
gender,any bacteria can cause UTI to any sex when the condition allow (Okwara et 
al., 2004). 
 
5.6 Co-morbidity of UTI and Malaria According to Age 
The prevalence of co infection reported in this study is 3.3%. children aged 26-37 
being the majority among the age cohort. Co-infection of malaria and UTI in 
children has been reported by several studies conducted across the World and 
particularly in African continent (Musa et al., 2003; Okwara et al., 2004; Okunola et 
al., 2012). Okwara et al. Biyikli et al 2004 reported 13.3% in Kenya among children 
aged 3 months to 12 years). The higher value in Okwara's study may be accounted 
for by the fact that a disproportionately higher number of young infants were 
included in that study. An earlier study by Musa et al.2003 and Biyikli et al 2004 in 
Benin City reported a prevalence of 6% in their sub-population with malaria, a figure 
that is still higher than what is recorded in this study. 
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5.7 Co-morbidity of UTI and Malaria According to sex 
 12 out of 366 children (3.3%) examined had growth of a single bacterial pathogen. 
Girls were slightly more than boys to have a co morbidity of malaria and 
UTI.Females were 7(58.66%) compared to males 5(41.33%) The study corraborates 
the findings as documented in other reports that   malaria in children can co-exist 
with UTI (Gleenson et al., 1991), and among boys, uncircumcised infants had an 
eightfold higher risk.  However, the spectrum of organisms found among this cohort 
is similar to what is obtainable for the general population, implying that malaria co-
existing with UTI is not due to any special group of organism(s).(Osegbe et al., 
1991).  
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     CHAPTER SIX 
6.0   CONCLUSION AND RECOMMENDATION 
 
Co-infection of malaria and UTI was present in 3.3% of febrile children under five 
years in Muhimbili National Hospital. Approximately one in every thirty children 
under five years of age managed for parasitologically proven malaria had 
concomitant UTI which could only be detected through extra efforts. Non-detection 
implies that such hidden morbidity would be untreated. Escherichia coli was the 
predominant cause of the UTI and the isolates were highly resistant to penicillin and 
Gentamycin but susceptible to ciprofloxacin, Septrine and nitrofurantoin. Health care 
personnel should rule out UTI when managing febrile children less than five  years 
with malaria. 
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        APPENDICES 
 
Appendix  1: Questionnaire 
 
Interview schedule for data collection of children under five years attending 
medical services for co-existence between malaria and UTI at MNH, 
 
SECTION A: INTRODUCTORY PART. 
1.  Interview number…………… 
2.  Date of interview……………. 
3.  Time of interview…………… 
 
You are free to answer these questions. You are allowed to ask any question where 
not clear. The interview is aiming at collecting data (information) about the co-
existence between Malaria and UTI diagnosis. All information given will be treated 
as confidential. 
SECTION B: QUESTIONS. 
The questions will be asked to the parents or guardians of the children. Tick the 
correct answer. 
1. How old is the child? 
a). 6-24months 
b) 25-36months 
c) 37-59months 
2. Is he/she getting fever 
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a).Yes 
b).No 
3. Is he/she getting difficult in urination? 
a).Yes 
b).No 
4. Has he/she been investigated for malaria? 
a)Yes 
b) No 
5. Has he/she been investigated for UTI? 
a)Yes 
b) No 
a) Has he/she been treated for malaria? 
b)Yes 
b) No 
7. Has he/she been treated for UTI? 
a)Yes 
b) No 
8. Is he/she having any urinary tract structural abnormality? 
a)Yes 
b) No 
Thank you very much for your cooperation. 
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Appendix  2: Consent Form 
 
CO-EXISTENCE OF UTI AND MALARIA AMONG CHILDREN UNDER 
FIVE YEARS AT MNH. 
 
Foreword 
My name is Albert Ntukula,Masters student from OUT.I am currently conducting a 
study on Co-existence of  UTI and Malaria attending at MNH. 
Research description: 
The study will take about eight months from November 2013 to June 2014. The 
findings from this study will bring the baseline useful information that will bring the 
improvement on diagnosis of co-morbidities in under five years and therefore proper 
management. 
I ask for your participation in the study on behalf of a child because she/he is among 
the patients admitted at MNH that is regarded as a group at risk. If you agree to 
participate in this study you will be requested to provide sample specimen for the 
study through laboratory investigation. 
Benefits: 
If you agree to participate you will have the following benefits; 
1. You will know if you are co-infected with UTI and Malaria as not 
previously identified. 
2. You will be managed according to the treatment guidelines if you have it. 
Risks: 
No risk can occur during your participation in urine specimen collection. 
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Confidentiality: 
All information obtained from you will be treated as confidential, and will be used 
for the intended purposes of this research. 
Compensation: 
I do not expect any harm to you as a result to your participation in the study, 
however, if it accidentally occurs there will be no compensation. 
Voluntary Participation and Withdrawal: 
You have the right to participate or not in the study without giving any reason for 
your decision,and you are free to terminate your participation at any time in the 
course of the study. 
Contacts: 
If you have any question about this study you are free to contact the principal 
investigator:Albert Ntukula(0716127128) or albert.ntukula@yahoo.com.If you have 
any question/concern about your rights as a participant you may contact Professor 
Emmanuel Kigadye, OUT, Po Box 23409 DSM. Tel no 0754 373756 
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Documentation: 
If you agree to participate, please sign this informed consent form. 
I……………………………………..,have read and understood the contents of the 
informed consent form and questions have been answered adequately. I therefore 
consent for participation in this study. 
Signature of the interviewee…………………………………Date…………………… 
Signature of the 
interviewer………………………………….Date…………………… 
 
 
 
